-Advertisement-

Evolus CFO Silvernail to Retire

Evolus Inc. (NASDAQ: EOLS), which is trying to compete with Allerganโ€™s Botox, said Lauren Silvernail will retire as chief financial officer, effective May 31.

The Newport Beach-based company said itโ€™s searching for her successor.

โ€œLauren has been instrumental in helping us build this company from a development stage organization to a fast-growing and well-funded commercial business,โ€ Chief Executive David Moatazedi said in a statement.

Most recently, she and the team negotiated a $125 million credit facility that is expected to fund Evolus through cash flow breakeven, which the company said removes โ€œthe need for further financing of its current operations.โ€

Evolus today also reported fourth-quarter revenue soared 68% to $34.7 million, confirming its preliminary report issued Jan. 26. Shares were relatively unchanged in after-hours trading around $9 and a $500 million market cap.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-